These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 11932386)

  • 1. Induction of long-term memory CD8(+) T cells for recall of viral clearing responses against influenza virus.
    Deliyannis G; Jackson DC; Ede NJ; Zeng W; Hourdakis I; Sakabetis E; Brown LE
    J Virol; 2002 May; 76(9):4212-21. PubMed ID: 11932386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intranasal lipopeptide primes lung-resident memory CD8+ T cells for long-term pulmonary protection against influenza.
    Deliyannis G; Kedzierska K; Lau YF; Zeng W; Turner SJ; Jackson DC; Brown LE
    Eur J Immunol; 2006 Mar; 36(3):770-8. PubMed ID: 16435281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipid-containing mimetics of natural triggers of innate immunity as CTL-inducing influenza vaccines.
    Lau YF; Deliyannis G; Zeng W; Mansell A; Jackson DC; Brown LE
    Int Immunol; 2006 Dec; 18(12):1801-13. PubMed ID: 17077175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-lasting anti-viral cytotoxic T lymphocytes induced in vivo with chimeric-multirestricted lipopeptides.
    Sauzet JP; Déprez B; Martinon F; Guillet JG; Gras-Masse H; Gomard E
    Vaccine; 1995 Oct; 13(14):1339-45. PubMed ID: 8585291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The context of epitope presentation can influence functional quality of recalled influenza A virus-specific memory CD8+ T cells.
    Day EB; Zeng W; Doherty PC; Jackson DC; Kedzierska K; Turner SJ
    J Immunol; 2007 Aug; 179(4):2187-94. PubMed ID: 17675478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intranasal administration of a synthetic peptide vaccine encapsulated in liposome together with an anti-CD40 antibody induces protective immunity against influenza A virus in mice.
    Ninomiya A; Ogasawara K; Kajino K; Takada A; Kida H
    Vaccine; 2002 Aug; 20(25-26):3123-9. PubMed ID: 12163263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The hepatitis B virus-specific CTL responses induced in humans by lipopeptide vaccination are comparable to those elicited by acute viral infection.
    Livingston BD; Crimi C; Grey H; Ishioka G; Chisari FV; Fikes J; Grey H; Chesnut RW; Sette A
    J Immunol; 1997 Aug; 159(3):1383-92. PubMed ID: 9233635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effective Respiratory CD8 T-Cell Immunity to Influenza Virus Induced by Intranasal Carbomer-Lecithin-Adjuvanted Non-replicating Vaccines.
    Gasper DJ; Neldner B; Plisch EH; Rustom H; Carrow E; Imai H; Kawaoka Y; Suresh M
    PLoS Pathog; 2016 Dec; 12(12):e1006064. PubMed ID: 27997610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Priming for virus-specific CD8+ but not CD4+ cytotoxic T lymphocytes with synthetic lipopeptide is influenced by acylation units and liposome encapsulation.
    Babu JS; Nair S; Kanda P; Rouse BT
    Vaccine; 1995 Dec; 13(17):1669-76. PubMed ID: 8719518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heterosubtypic immunity against human influenza A viruses, including recently emerged avian H5 and H9 viruses, induced by FLU-ISCOM vaccine in mice requires both cytotoxic T-lymphocyte and macrophage function.
    Sambhara S; Kurichh A; Miranda R; Tumpey T; Rowe T; Renshaw M; Arpino R; Tamane A; Kandil A; James O; Underdown B; Klein M; Katz J; Burt D
    Cell Immunol; 2001 Aug; 211(2):143-53. PubMed ID: 11591118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficiency of peptides and lipopeptides for in vivo priming of virus-specific cytotoxic T cells.
    Schild H; Deres K; Wiesmüller KH; Jung G; Rammensee HG
    Eur J Immunol; 1991 Nov; 21(11):2649-54. PubMed ID: 1936113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of influenza virus-specific cytotoxic T-lymphocyte responses induced by a synthetic nucleoprotein peptide on the survival of mice challenged with a lethal dose of virus.
    Sastry KJ; Bender BS; Bell W; Small PA; Arlinghaus RB
    Vaccine; 1994 Nov; 12(14):1281-7. PubMed ID: 7856292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipopeptide particles as the immunologically active component of CTL inducing vaccines.
    Tsunoda I; Sette A; Fujinami RS; Oseroff C; Ruppert J; Dahlberg C; Southwood S; Arrhenius T; Kuang LQ; Kubo RT; Chesnut RW; Ishioka GY
    Vaccine; 1999 Feb; 17(7-8):675-85. PubMed ID: 10067673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fine specificity of cytotoxic T lymphocytes primed in vivo either with virus or synthetic lipopeptide vaccine or primed in vitro with peptide.
    Schild H; Norda M; Deres K; Falk K; Rötzschke O; Wiesmüller KH; Jung G; Rammensee HG
    J Exp Med; 1991 Dec; 174(6):1665-8. PubMed ID: 1744592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heterosubtypic immunity to lethal influenza A virus infection is associated with virus-specific CD8(+) cytotoxic T lymphocyte responses induced in mucosa-associated tissues.
    Nguyen HH; Moldoveanu Z; Novak MJ; van Ginkel FW; Ban E; Kiyono H; McGhee JR; Mestecky J
    Virology; 1999 Feb; 254(1):50-60. PubMed ID: 9927573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protection against lethal viral infection by vaccination with nonimmunodominant peptides.
    Oukka M; Manuguerra JC; Livaditis N; Tourdot S; Riche N; Vergnon I; Cordopatis P; Kosmatopoulos K
    J Immunol; 1996 Oct; 157(7):3039-45. PubMed ID: 8816413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of protective class I MHC-restricted CTL in mice by a recombinant influenza vaccine in aluminium hydroxide adjuvant.
    Dillon SB; Demuth SG; Schneider MA; Weston CB; Jones CS; Young JF; Scott M; Bhatnaghar PK; LoCastro S; Hanna N
    Vaccine; 1992; 10(5):309-18. PubMed ID: 1349448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of T cell help and endoplasmic reticulum targeting in protective CTL response against influenza virus.
    Langlade-Demoyen P; Garcia-Pons F; Castiglioni P; Garcia Z; Cardinaud S; Xiong S; Gerloni M; Zanetti M
    Eur J Immunol; 2003 Mar; 33(3):720-8. PubMed ID: 12616492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipopeptide immunization without adjuvant induces potent and long-lasting B, T helper, and cytotoxic T lymphocyte responses against a malaria liver stage antigen in mice and chimpanzees.
    BenMohamed L; Gras-Masse H; Tartar A; Daubersies P; Brahimi K; Bossus M; Thomas A; Druilhe P
    Eur J Immunol; 1997 May; 27(5):1242-53. PubMed ID: 9174617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Viral escape by selection of cytotoxic T cell-resistant variants in influenza A virus pneumonia.
    Price GE; Ou R; Jiang H; Huang L; Moskophidis D
    J Exp Med; 2000 Jun; 191(11):1853-67. PubMed ID: 10839802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.